# A Retrospective Study to Evaluate the Predictability of Abnormal Arterial Blood Gas Measurements Through Novel Observations of Continuous Trends in Electronically Measured Respiratory Rate in a Mixed Cohort of Respiratory Compromised Patients

> **NCT05384314** · — · UNKNOWN · sponsor: **Beaumont Hospital** · enrollment: 322 (estimated)

## Conditions studied

- Respiratory Failure
- COPD
- Pneumonia
- Community-acquired Pneumonia
- COVID-19
- Pulmonary Disease

## Interventions

- **DEVICE:** RespiraSense

## Key facts

- **NCT ID:** NCT05384314
- **Lead sponsor:** Beaumont Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-12
- **Primary completion:** 2022-10-12
- **Final completion:** 2022-12-12
- **Target enrollment:** 322 (ESTIMATED)
- **Last updated:** 2022-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05384314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05384314, "A Retrospective Study to Evaluate the Predictability of Abnormal Arterial Blood Gas Measurements Through Novel Observations of Continuous Trends in Electronically Measured Respiratory Rate in a Mixed Cohort of Respiratory Compromised Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05384314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*